SCHEMBL19080160

SCHEMBL19080160

c1ccc2c(c1)ccc1oc3cc4cc(-c5ccc(-c6c7ccccc7c(-c7ccc8oc9ccccc9c8c7)c7ccccc67)cc5)ccc4cc3c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
ABCG2 Q9UNQ0 5/20 0.36
NPC1 O15118 3/20 0.36
AHR P35869 3/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
PAX8 Q06710 2/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
FYN P06241 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080161 0.94 MAPT (0.41) CASP3SENP7SENP6NPC1AHR
SCHEMBL24341315 0.92 CASP3 (0.40) CASP3SENP7SENP6NPC1AHR
SCHEMBL19079994 0.92 ABCG2 (0.39) ABCG2NPC1AHRRAB9ATDP1
SCHEMBL20127312 0.92 NPC1 (0.41) CASP3SENP7SENP6ABCG2NPC1
SCHEMBL24848969 0.92 NPC1 (0.41) CASP3SENP7SENP6ABCG2NPC1
SCHEMBL19076589 0.91 MAPT (0.41) CASP3SENP7SENP6NPC1AHR
SCHEMBL16067689 0.91 ABCG2 (0.41) ABCG2NPC1AHRRAB9AKDM4E
SCHEMBL19080034 0.90 ABCG2 (0.45) ABCG2NPC1AHRRAB9ATDP1
SCHEMBL19079942 0.90 ABCG2 (0.45) ABCG2NPC1AHRRAB9ATDP1
SCHEMBL10122513 0.90 ABCG2 (0.40) CASP3SENP7SENP6ABCG2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CASP3 2441/4885SENP7 3800/4885SENP6 4077/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CASP3 2441/4885SENP7 3800/4885SENP6 4077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.